Digital Gene Expression Analysis by 3’ End Sequencing
Award amount
$270,000Program and phase
STTR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOO SCIENTIFIC CORPORATION
- Proposal award date
- 2016-04-01
- Contract end date
- 2018-03-31
- UEI
- Z24GLNTRPBT5
- Solicitation number
- PA14-072
- Topic code
- 172
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Sequencing of Epigenetic Modifications from Single Cells
- TARGETED THERAPEUTIC ANTIBODY MOLECULES AGAINST VIRAL ENCEPHALITIS
- Burkholderia antibody molecules for therapeutics and diagnostics
- SBIR Phase II: High-throughput Small RNA Sequencing
- Burkholderia antibody molecules for therapeutics and diagnostics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DNA-optical barcoding technology for spatiotemporal single-cell analysis
- CRISPR-based depletion method for resolving pseudogene contamination in Next Generation Sequencing (NGS) based genetic testing
- Pioneering assays for spatially-resolved single-cell multiomics
- A Novel Instrument and Consumables for Quality Control in Next Generation Sequencing
- Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kinetics
Research funding history
26 SBIR/STTR records share this UEI (2007–2016). Reported award amounts total $7,244,135. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Defense, Department of Agriculture